{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-145741","form_type":"8-K","ticker":"VRDN","cik":"0001590750","company_name":"Viridian Therapeutics, Inc.\\DE","filed_at":"2025-06-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:48.922678+00:00","generated_at":"2026-05-18T22:33:45.354946+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Viridian shareholders approve 8M-share increase in equity plan in close vote","bullets":["Stockholders narrowly approved amendment to increase equity plan shares by 8,000,000 (35.3M for, 35.1M against).","Three Class I directors elected: Jeff Ajer, Chris Cain, Sarah Gheuens.","Ratification of KPMG as auditor, advisory say-on-pay, and 2025 ESPP all passed.","Close 49.8% opposition on equity plan reflects significant shareholder dissent."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-145741","json":"https://secwatch.observer/filing/0001193125-25-145741.json","markdown":"https://secwatch.observer/filing/0001193125-25-145741.md","text":"https://secwatch.observer/filing/0001193125-25-145741.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1590750/000119312525145741/0001193125-25-145741-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1590750/000119312525145741/d871650d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T22:33:45.354946+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}